Autoimmune & immunology · Phase III

Top sponsors

• Takeda 39 programs
• Janssen-Cilag International N.V 26 programs
• Anaxis Pharma 20 programs
• AbbVie 18 programs
• Novartis India 17 programs
• AbbVie Deutschland GmbH 13 programs
• HOFFMANN-LA ROCHE 11 programs
• Eli Lilly and 9 programs
• Chinese Academy of 8 programs
• Bristol-Myers Squibb Australia 7 programs
• PARItec 7 programs
• Pacira Ireland 7 programs

1. Anifrolumab

   AstraZeneca

   Systemic Lupus Erythematosus

   phase 3 · mab · active

   1 trial →

2. Anifrolumab

   AstraZeneca

   Cutaneous Lupus Erythematosus

   phase 3 · other · active

   1 trial →

3. Anifrolumab

   AstraZeneca

   Lupus Nephritis

   phase 3 · small molecule · active

   1 trial →

4. Anifrolumab

   AstraZeneca

   Active Systemic Lupus Erythematosus

   phase 3 · mab · completed

   3 trials →

5. Anifrolumab

   AstraZeneca AB

   Moderate-to-severe Systemic Lupus Erythematosus (SLE)

   phase 3 · small molecule · active

   1 trial →

6. Apremilast 20mg

   Amgen

   Psoriatic Arthritis

   phase 3 · small molecule · completed

   1 trial →

7. Asacol®

   Tillotts Pharma AG

   Active Ulcerative Colitis

   phase 3 · small molecule · completed

   1 trial →

8. Atacicept

   Vera Therapeutics

   Lupus Nephritis (LN)

   phase 3 · small molecule · terminated

   1 trial →

9. Azathioprine

   The First People's Hospital of Lianyungang

   Myasthenia Gravis

   phase 3 · small molecule · completed

   1 trial →

10. B007

    BRIGHT MINDS BIOSCIENCES INC.

    Generalized Myasthenia Gravis

    phase 3 · small molecule · active

    1 trial →

11. BI 695501

    Boehringer Ingelheim

    Arthritis, Rheumatoid

    phase 3 · small molecule · completed

    2 trials →

12. BIIB059

    Biogen

    1. Lupus Erythematosus, Cutaneous, Subacute 2. Chronic Cutaneous Lupus Erythematosus

    phase 3 · small molecule · active

    1 trial →

13. Baricitinib

    Eli Lilly and Company

    Systemic Juvenile Idiopathic Arthritis

    phase 3 · small molecule · active

    1 trial →

14. Baricitinib

    Eli Lilly and Company

    Systemic Lupus Erythematosus

    phase 3 · small molecule · terminated

    1 trial →

15. Budesonide

    Bausch + Lomb Ireland Limited

    Colitis, Ulcerative

    phase 3 · small molecule · completed

    1 trial →

16. Bupivacaine Liposome Injection

    United Therapeutics Europe Ltd

    Osteoarthritis

    phase 3 · small molecule · terminated

    1 trial →

17. C5041006

    Lacuna Pharma Pty Ltd

    Crohn's Disease

    phase 3 · small molecule · active

    1 trial →

18. CA41705

    Hoffmann-La Roche

    Lupus Nephritis (LN)

    phase 3 · small molecule · active

    1 trial →

19. CA42750

    Hoffmann-La Roche

    Systemic Lupus Erythematosus (SLE)

    phase 3 · small molecule · active

    1 trial →

20. CEP-33457

    Teva Pharma GmbH

    Systemic Lupus Erythematosus

    phase 3 · small molecule · completed

    2 trials →

21. CF101

    Can-Fite BioPharma

    Plaque Psoriasis

    phase 3 · small molecule · completed

    1 trial →

22. CF101 1 mg

    Can-Fite BioPharma

    Rheumatoid Arthritis

    phase 3 · small molecule · terminated

    1 trial →

23. CF101 2mg

    Can-Fite BioPharma

    Plaque Psoriasis

    phase 3 · small molecule · completed

    1 trial →

24. CHS-0214

    Coherus Oncology

    Rheumatoid Arthritis

    phase 3 · small molecule · completed

    1 trial →

25. CHS-1420

    Coherus Oncology

    Plaque Psoriasis

    phase 3 · small molecule · completed

    1 trial →

26. CLNP023Q12301

    Novartis Pharmaceuticals

    generalized Myasthenia Gravis

    phase 3 · small molecule · active

    1 trial →

27. CLOU064O12301

    Novartis Pharmaceuticals

    Generalized Myasthenia Gravis

    phase 3 · small molecule · active

    1 trial →

28. CLS2901C (human [allogeneic] chondrocyte sheets)

    CellSeed Europe Ltd

    Osteoarthritis of the Knee

    phase 3 · mab · active

    1 trial →

29. CNTO1275JPA3001

    Janssen-Cilag International N.V.

    Juvenile psoriatic arthritis

    phase 3 · small molecule · active

    1 trial →

30. CNTO148UCO3003

    Janssen-Cilag Pty Ltd

    Ulcerative Colitis

    phase 3 · small molecule · active

    1 trial →

31. CNTO1959CRD3001

    Janssen-Cilag International N.V.

    Moderately to Severely Active Crohn's Disease

    phase 3 · small molecule · active

    1 trial →

32. CNTO1959CRD3004

    Janssen-Cilag International N.V.

    Moderately to Severely Active Crohn's Disease

    phase 3 · small molecule · active

    1 trial →

33. CNTO1959CRD3005

    Janssen-Cilag International N.V.

    Fistulizing perianal Crohn's Disease

    phase 3 · small molecule · active

    1 trial →

34. CNTO1959CRD3008

    Janssen-Cilag International N.V.

    Crohn’s Disease

    phase 3 · small molecule · active

    1 trial →

35. CNTO1959ISD3001

    Janssen-Cilag International N.V.

    Juvenile psoriatic arthritis (jPsA), Moderately to severely active ulcerative colitis (UC), Moderately to severely active Crohn's disease (CD)

    phase 3 · small molecule · active

    1 trial →

36. CNTO1959PBCRD3007

    Janssen-Cilag International N.V.

    Moderately to Severely Active Crohn's Disease

    phase 3 · small molecule · active

    1 trial →

37. CNTO1959PSA3004

    Janssen-Cilag International N.V.

    Psoriatic arthritis (PsA)

    phase 3 · small molecule · active

    1 trial →

38. CNTO1959PSA3005

    Janssen-Cilag International N.V.

    Psoriatic Arthritis

    phase 3 · small molecule · active

    1 trial →

39. CNTO1959PSO3012

    Janssen-Cilag International N.V.

    Moderate to Severe Plaque Type Psoriasis

    phase 3 · small molecule · active

    1 trial →

40. CNTO1959PUC3001

    Janssen-Cilag International N.V.

    Ulcerative Colitis

    phase 3 · small molecule · active

    1 trial →

41. CNTO1959UCO3001

    Janssen-Cilag International N.V.

    Moderately to Severely Active Ulcerative Colitis

    phase 3 · small molecule · active

    1 trial →

42. CNTO1959UCO3004

    Janssen-Cilag International N.V.

    Moderate to Severly Active Ulcerative Colitis

    phase 3 · small molecule · active

    1 trial →

43. CONDROSULF 800 mg tabletta

    The George Institute

    Knee osteoarthritis with moderate to severe pain

    phase 3 · small molecule · active

    1 trial →

44. CP-690,550

    Pfizer

    Arthritis, Rheumatoid

    phase 3 · small molecule · completed

    3 trials →

45. CT-P13 3.11

    Celltrion Healthcare Australia Pty Ltd

    Rheumatoid arthritis

    phase 3 · small molecule · active

    1 trial →

46. CT-P55 3.1

    Celltrion Healthcare Australia Pty Ltd

    Plaque psoriasis

    phase 3 · small molecule · active

    1 trial →

47. CVAY736B2201

    Novartis Pharmaceuticals

    Autoimmune hepatitis

    phase 3 · small molecule · active

    1 trial →

48. CVAY736F12301

    Novartis Pharmaceuticals

    Systemic Lupus Erythematosus

    phase 3 · small molecule · active

    1 trial →

Frequently asked questions